ArticleBMC health services research2021

Cost-effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China.

Hongtao Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.